Venture Partner at Catalio Capital Management
View Live Interactive Profile →Catalio Capital Management lists Justin Hanes as a Venture Partner. The firm's profile page gives the current affiliation as Director, Center of Nanomedicine at Johns Hopkins Medicine. His stated honours include election to the National Academy of Inventors (2014) and inclusion in the MIT Technology Review 35 Innovators Under 35 (2003). Catalio's page lists him as a co-founder of Kala Pharmaceuticals, GrayBug Vision, Ashvattha Therapeutics, Orpheris, Theraly Fibrosis, Neuraly, Spiral Therapeutics, Advanced Inhalation Research and Civitas Therapeutics.